1. Bal, Elodie, Kumar, Rahul, Hadigol, Mohammad, Pasqualucci, Laura, Dalla-Favera, Riccardo. 2022. Super-enhancer hypermutation alters oncogene expression in B cell lymphoma. In Nature, 607, 808-815. doi:10.1038/s41586-022-04906-8. https://pubmed.ncbi.nlm.nih.gov/35794478/
2. Louwen, Frank, Kreis, Nina-Naomi, Ritter, Andreas, Solbach, Christine, Yuan, Juping. . BCL6, a key oncogene, in the placenta, pre-eclampsia and endometriosis. In Human reproduction update, 28, 890-909. doi:10.1093/humupd/dmac027. https://pubmed.ncbi.nlm.nih.gov/35640966/
3. Dietlein, Felix, Wang, Alex B, Fagre, Christian, Neal, James T, Van Allen, Eliezer M. 2022. Genome-wide analysis of somatic noncoding mutation patterns in cancer. In Science (New York, N.Y.), 376, eabg5601. doi:10.1126/science.abg5601. https://pubmed.ncbi.nlm.nih.gov/35389777/
4. Baron, Beverly W, Anastasi, John, Thirman, Michael J, Zeleznik-Le, Nancy, McKeithan, Timothy W. 2002. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis. In Proceedings of the National Academy of Sciences of the United States of America, 99, 2860-5. doi:. https://pubmed.ncbi.nlm.nih.gov/11854457/